CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions. - Patil T; Lin JJ; Cheema PK; Carrizosa DR; Burkard ME; Elamin YY; Desai J; Patel JD; Nagasaka M; Reckamp KL; Waqar SN; Bauman JR; et al. (JCO precision oncology, 2025)